158 related articles for article (PubMed ID: 38169579)
1. LncRNA
Li X; Liang S; Fei M; Ma K; Sun L; Liu Y; Liu L; Wang J
Int J Biol Sci; 2024; 20(2):718-732. PubMed ID: 38169579
[TBL] [Abstract][Full Text] [Related]
2. LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma.
Xie SC; Zhang JQ; Jiang XL; Hua YY; Xie SW; Qin YA; Yang YJ
Cell Death Dis; 2020 Aug; 11(8):676. PubMed ID: 32826865
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long noncoding RNA colorectal neoplasia differentially expressed inhibits hepatocellular carcinoma progression by mediating the expression of nuclear autoantigenic sperm protein.
Zhu Y; Li B; Xu G; Han C; Xing G
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34633056
[TBL] [Abstract][Full Text] [Related]
4. LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/ BCAT1 axis.
Ji D; Jiang C; Zhang L; Liang N; Jiang T; Yang B; Liang H
J Cell Physiol; 2019 May; 234(5):6548-6560. PubMed ID: 30230527
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
[TBL] [Abstract][Full Text] [Related]
6. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
[TBL] [Abstract][Full Text] [Related]
8. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CRNDE promotes heptaocellular carcinoma cell proliferation by regulating PI3K/Akt /β-catenin signaling.
Tang Q; Zheng X; Zhang J
Biomed Pharmacother; 2018 Jul; 103():1187-1193. PubMed ID: 29864897
[TBL] [Abstract][Full Text] [Related]
11. CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance.
Liu YC; Lin YH; Chi HC; Huang PS; Liao CJ; Liou YS; Lin CC; Yu CJ; Yeh CT; Huang YH; Lin KH
Clin Epigenetics; 2022 Aug; 14(1):106. PubMed ID: 35999564
[TBL] [Abstract][Full Text] [Related]
12. LncRNA CRNDE is involved in radiation resistance in hepatocellular carcinoma via modulating the SP1/PDK1 axis.
Chen KY; Zhu SG; He JW; Duan XP
Neoplasma; 2022 Jul; 69(4):918-930. PubMed ID: 35652619
[TBL] [Abstract][Full Text] [Related]
13. Long-Noncoding RNA Colorectal Neoplasia Differentially Expressed Gene as a Potential Target to Upregulate the Expression of IRX5 by miR-136-5P to Promote Oncogenic Properties in Hepatocellular Carcinoma.
Zhu L; Liu Y; Chen Q; Yu G; Chen J; Chen K; Yang N; Zeng T; Yan S; Huang A; Tang H
Cell Physiol Biochem; 2018; 50(6):2229-2248. PubMed ID: 30423553
[TBL] [Abstract][Full Text] [Related]
14. PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.
Wang N; Tan HY; Lu Y; Chan YT; Wang D; Guo W; Xu Y; Zhang C; Chen F; Tang G; Feng Y
Signal Transduct Target Ther; 2021 Feb; 6(1):86. PubMed ID: 33633112
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA 00607 as a tumor suppressor by modulating NF-κB p65/p53 signaling axis in hepatocellular carcinoma.
Sun QM; Hu B; Fu PY; Tang WG; Zhang X; Zhan H; Sun C; He YF; Song K; Xiao YS; Sun J; Xu Y; Zhou J; Fan J
Carcinogenesis; 2018 Dec; 39(12):1438-1446. PubMed ID: 30169594
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
[TBL] [Abstract][Full Text] [Related]
17. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling.
Tian X; Wu Y; Yang Y; Wang J; Niu M; Gao S; Qin T; Bao D
Mol Oncol; 2020 Feb; 14(2):462-483. PubMed ID: 31785055
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CRNDE triggers inflammation through the TLR3-NF-κB-Cytokine signaling pathway.
Li H; Li Q; Guo T; He W; Dong C; Wang Y
Tumour Biol; 2017 Jun; 39(6):1010428317703821. PubMed ID: 28621230
[TBL] [Abstract][Full Text] [Related]
20. Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma.
Wang T; Zhu H; Xiao M; Zhou S
J Clin Lab Anal; 2021 Nov; 35(11):e23959. PubMed ID: 34612554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
